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Edited by Robert BaroukiAbstract Peptides that target tissue for an apoptotic death have
potential as therapeutics in a variety of disease conditions. The
class of peptides described herein enters the cell through a spe-
ciﬁc receptor-mediated interaction. Once inside the cell, the pep-
tide migrates toward the mitochondria, where the membrane
barrier is disrupted. These experiments demonstrate that upon
treatment with these short peptides large unilamellar vesicles
are not lysed, a graded mode of leakage is observed and the tran-
sient pores formed by these peptides are large enough to release
entrapped cytochrome c from the vesicles.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Cell penetrating peptide1. Introduction
Peptide ligands that interact with cell surface receptors and
induce apoptosis can be valuable lead compounds into the de-
sign of targeted therapy for a variety of disease conditions.
Recent studies report high-throughput screening for peptide-
induced apoptosis via mimicry of the TNF-related apoptosis-
inducing ligand (TRAIL): tumor necrosis factor (TNF)
interaction [1] and other cell surface receptors [2,3]. The class
of peptides described herein, hunter-killer peptides (HKPs)
use receptor interactions as a vehicle for intracellular delivery
and have been reported for targeting angiogenic tumor vascu-
lature [4], white adipose tissue [5], and arthritic tissue [6]. These
pro-apoptotic peptides contain a variable amino terminal
homing sequence, which mediates interactions with cell surface
receptors, and a common positively charged carboxyl terminal
apoptosis sequence motif that is connected through a glycinyl
glycine linker (Fig. 1). Once inside the cell, the peptide initiates
apoptosis through a membrane perturbing interaction with the
mitochondria [4]. The apoptotic sequence is comprised of D-
amino acids to increase the in vivo stability. NMR derivedAbbreviations: FD4, ﬁtc-dextran 4 kDa; FD10, ﬁtc-dextran 10 kDa;
FD20, ﬁtc-dextran 20 kDa; FD40, ﬁtc-dextran 40 kDa; FD70, ﬁtc-
dextran 70 kDa; ﬁtc, ﬂuorescein isothiocyanate; HKP, hunter-killer
peptide; LUVs, large unilamellar vesicles; Mst, mastoparan; PC,
phosphatidylcholine; PG, phosphatidylglycerol; TNF, tumor necrosis
factor; TRAIL, TNF-related apoptosis-inducing ligand
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doi:10.1016/j.febslet.2007.10.051structures in the presence of lipid micelles have been reported
[7,8] for two peptides that target angiogenic tumor cells for
apoptosis but the mechanism of their interaction with lipid
bilayers is unknown.
Cell penetrating peptides (CPPs) are another class of cat-
ionic peptides that include penetratin, tat, and transportan,
which cross the cell membrane. Several mechanisms of intra-
cellular transport have been proposed for these peptides
[9,10]. CPPs have been modiﬁed for delivery of cargo including
peptides [11] and nucleic acids [12–14] to intracellular targets;
however, cellular uptake and toxicity have been shown to be
cargo dependent [15–17]. Hunter-killer peptides (HKPs) have
some similarity to CPPs, but transport into cells is targeted
by the receptor-speciﬁc homing sequence. HKPs have demon-
strated approximately tenfold selective toxicity for targeted
cells over cells not expressing the receptor [5] and selective
reduction in body mass in white adipose tissue [4,5].
The potential therapeutic activity of HKPs is based upon
their ability to induce apoptosis. Release of cytochrome c into
the cytoplasm stimulates assembly of the apoptosome, subse-
quent activation of caspase-9 [18,19] and apoptosis. In this
work, we report experiments that characterize interactions
between HKPs with two diﬀerent homing sequences and large
phospholipid unilamellar vesicles (LUVs). These experiments
show that when vesicles are treated with peptide, the vesicles
are not lysed and that transient pores with deﬁned size are
formed. The ability of these peptides to induce eﬄux of cyto-
chrome c is investigated as well as the impact of swapping
homing sequences. Relative insensitivity to the homing
sequence will suggest the potential for wider application of
these peptides for potential therapeutic treatment of disease.2. Materials and methods
2.1. Materials
Egg phosphatidylglycerol (PG) and egg phosphatidylcholine (PC),
were purchased from Avanti Polar Lipids (Alabaster, AL). Fluorescein
isothiocyanate (Fitc)-dextrans of 4 kDa (FD4), 10 kDa (FD10),
20 kDa (FD20), 40 kDa (FD40), 70 kDa (FD70) size, bee venom mas-
toparan and bovine heart cytochrome c were purchased Sigma–Al-
drich (St. Louis, MO). Immunoblotting was done on Protran
BA83, 0.2 lmmembrane (VWR, Cat. No. 89026-732) using a Minifold
II System (Whatman, Schleicher & Schuell). The membrane was
probed with a 1:1000 dilution of mouse anti-cytochrome c monoclonal
antibody (Clone 2B5.F8) purchased from Assay Designs Inc.
2.2. Creation of large unilamellar vesicles
LUVs were made by drying down phospholipids from a chloroform
solution and vacuum dried overnight. The lipids were suspended withblished by Elsevier B.V. All rights reserved.
Table 1
Determination that homing pro-apoptotic peptides induce graded
mode of leakage
HKP1 Mst Control
It/Io, before 4.4 4.4 4.4
L (%) 63 69 0
It/Io, after 2.3 2.3 5.7
Fig. 1. Sequences for HKP1, HKPao and mastoparan. The amino
acids of the pro-apoptotic sequence of HKP1 and HKPao have D-
stereochemical conﬁguration and are shown in lower case letters.
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in 20 mM HEPES buﬀer pH 7.5 to a phospholipid concentration of
35 mM. Suspensions were vortexed and placed in a water bath at
45 C for 5 min and repeated until the phospholipids were suspended.
Five freeze/thaw cycles in N2 (l) were performed. The sample was
placed in an extruder containing 2 stacked membranes (100 nm) and
then passed 11 times. The vesicles were passed over a 60 ml Sephacryl
S-300 or Sephracyl S-100 (GE Healthcare) column to separate the ves-
icles from dye, ﬁtc-dextrans or cytochrome c. Total phospholipid con-
centration was assayed by a modiﬁed phosphate assay [20]. Vesicles
eluted from gel ﬁltration generally contained approximately 1 mM
phospholipid.
2.3. Vesicle leakage studies
All ﬂuorescence measurements were carried out on a Jasco FP6600
spectroﬂuorometer equipped with Pelletier temperature controller at
25 C. Leakage experiments with calcein and ﬁtc-dextran entrapped
vesicles were performed as described previously [8,21]. Baseline ﬂuores-
cence (Io) was measured on samples containing 20 mM HEPES buﬀer
and 30 ll of the collected vesicles diluted to 3 ml. Peptide was then
added and another ﬂuorescence measurement (IP) was taken. Total
leakage (It) was measured after addition of 5% Triton X-100 to a ﬁnal
concentration of 0.01%. Percent leakage was calculated by the equa-
tion: %L = (IP  Io)/(It  Io) · 100. Phospholipid assays were carried
out after leakage experiments [20]. Leakage assays were carried out
within 24 h of creation of the vesicles.
2.4. Mode of leakage
Calcein entrapped LUVs with 70:30 PC:PG molar ratio were created
and separated from the free dye as described above. The bee venom
peptide, mastoparan was used as a positive control. Details of these
experiments and graded mode of leakage by mastoparan X and mag-
ainin have previously been reported [22,23]. These vesicles were diluted
tenfold in 20 mMHEPES, pH 7.0. Mastoparan or HKP1 was added to
a concentration of 4 lM to vesicles at a peptide:lipid ratio of 0.04 to
induce leakage. For a negative control, buﬀer was added in place of
peptide. From the peptide treated samples and the control, 300 ll
was removed for a tenfold dilution upon which leakage was quantiﬁed
via ﬂuorescence measurements. Triton X-100 was added to determine
100% leakage. The quench factor (It/Io) was determined for the vesicles
prior to leakage. The remaining leakage sample was loaded onto gel
ﬁltration column to separate the free dye formed from leakage
from the vesicles. The vesicle eluent was collected and It/Io was remea-
sured.
2.5. Hydrodynamic radius of ﬁtc-dextrans and cytochrome c
The stokes radius of the ﬁtc-dextrans are reported by the manufac-
turer (Sigma), and the stokes radius of cytochrome c is reported [24].
Because dextrans are linear and cytochrome c is globular, we carried
out experiments that would provide relative hydrodynamic size of
FD4, FD10, FD20 and cytochrome c under the identical conditions
using gel ﬁltration chromatography. The column (1.5 cm diameter)
was packed with Sephacryl-S100 resin (GE Health Sciences) with a
bed volume of 55 ml and equilibrated with three column volumes of
50 mM Tris, 150 mM NaCl pH 7.5 (column buﬀer). Fitc-dextrans
(FD4, FD10 and FD20) were loaded in samples containing 15 mg in
500 ll of column buﬀer. Cytochrome c samples containing 10 mg/ml
in 500 ll of column buﬀer were loaded onto the column. The column
ﬂow rate was 0.9 ml/min for all samples. Elution was monitored by
absorbance at 280 nm.2.6. Detection and analysis of cytochrome c leakage from LUVs
Cytochrome c loaded vesicles were treated with HKP1 to ﬁnal con-
centrations of 4.6 lM, 11.5 lM, 23 lM and 46 lM. Untreated vesicle
samples were used as the controls to verify stability of the vesicles. To-
tal leakage of cytochrome c was demonstrated by addition of Triton X-
100 to a ﬁnal concentration of 1.1%. At the higher concentrations re-
quired for these experiments, the vesicle suspensions became turbid
with treatment of peptide, suggesting fusion of vesicles. In order to
avoid interference with gel ﬁltration, HKP1 treated vesicles were cen-
trifuged at 13000 · g for 30 s at room temperature prior to column
separation to sediment fused vesicles. Vesicles and free cytochrome c
in the supernatant were separated by gel ﬁltration. Fractions were col-
lected and immunoblotted with cytochrome c antibody. The vesicle
pellets were resuspended in 300 mM NaCl, 20 mM HEPES, pH 7.5,
monitored for relative turbidity by OD 280 nm and transferred to a
nitrocellulose membrane, which was probed with a monoclonal anti-
cytochrome c antibody followed by alkaline phosphatase detection
to verify retention of cytochrome c in the fused vesicles.3. Results
3.1. Graded mode of leakage
Initial experiments (Table 1) indicated the HKP1 undergoes
graded leakage and that the vesicles remain intact after treat-
ment with the peptide. The experiment was performed in par-
allel with mastoparan (Mst), a pore forming peptide with a
graded mode of leakage that we have observed previously.
Graded mode of leakage [23] has been reported for mastoparan
X. The relative ﬂuorescence (It/Io) is not expected to increase
for the control sample, but may be the result of incomplete
separation of vesicles from free calcein in the initial puriﬁca-
tion of vesicles, which are at tenfold higher concentration than
subsequent separations. The quench factor (It/Io) was plotted
as a function of peptide concentration and leakage. Fig. 2
shows that calcein self-quenching decreases as a function of
HKP1 concentration until 7 lM HKP1, where quenching
ceases because 100% leakage has occurred. The quench factor
is linear with leakage, demonstrating that the vesicles lose a
portion of their contents when they undergo leakage
(Fig. 2B). This graded mode of leakage is estimated to have
an upper limit of 5 ms for the lifetime of the pore, through
which the contents diﬀuse [25].
3.2. Hydrodynamic radius of molecules released from vesicles by
HKPs
HKP1 and HKPao can induce leakage of ﬂuorescent dex-
trans from vesicles that have a larger hydrodyanmic radius
than cytochrome c (Fig. 3A). Similar size dependence proﬁles
suggest that the size of the transient pores formed by both
these peptides are the same. Fitc-dextrans have self-quenching
properties [26–28], and ﬂuorescence intensity increases as the
local concentration of dye decreases with leakage from vesi-
cles. FD4 and FD10 both leak from vesicles with high eﬃ-
ciency under the same peptide:phospholipid ratios that have
Fig. 2. A plot of It/Io against peptide concentration (A) and leakage (B). Decreasing It/Io with leakage indicates partial leakage of vesicle contents,
and therefore survival of vesicles to treatment with peptide.
Fig. 3. (A) For the determination of size of molecules that can leak from vesicles with treatment of peptide, eﬄux of entrapped FD dyes of 4 kDa,
10 kDa, 20 kDa and 70 kDa size from 70:30 molar ratio PC:PG vesicles was monitored. Eﬄux of the ﬁtc-dextrans was detected via loss of
ﬂuorescence self-quenching [26] at 520 nm for 5 min. Excitation was at 490 nm with excitation and emission slit widths set to 1 nm. The assay
concentration of peptide and phospholipid were 150 nM and 14 ± 3 lM, respectively, for all experiments. The stokes radius of cytochrome c (1.7 nm)
[24] is represented by the dotted line. (B) Elution of FD4, FD10 and cytochrome c from gel ﬁltration chromatography demonstrates relative
hydrodynamic radius under identical conditions.
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The size of the pore appears to become limiting for molecules
with size between FD10 and FD20, which have a stokes radius
of 2.3 nm and 3.3 nm [29]. Minimal leakage occurs for dyes
larger than FD20. Gel ﬁltration chromatography veriﬁed the
relative hydrodynamic radii of FD10, FD4 and cytochrome c
(Fig. 3B), demonstrating that cytochrome c is of intermediate
size between the 1.4 nm and 2.3 nm reported for FD4 and
FD10.
3.3. Cytochrome c leakage from LUVs
Treatment of PC:PG vesicles with HKP1 initiated release of
entrapped cytochrome c (Fig. 4) in a concentration dependent
fashion at peptide:lipid ratios ranging from 0.007 to 0.07, in
the same range as the ﬁtc-dextran experiments described
earlier. Additionally, at the millimolar concentrations of
phospholipid required for these experiments, an increase in
sample turbidity was observed upon addition of peptide, sug-gesting vesicle fusion or aggregation is also induced by
HKP1. Chromatographic separation of the vesicles (11 ml elu-
tion volume) from released cytochrome c (33 ml) is shown in
Fig. 4A–D as a function of HKP1 concentration. Little change
in the elution proﬁle was observed relative to untreated vesicles
in the presence of 4.6 lM (data not shown). At 11.5 lM of
HKP1, the vesicle peak area is 50% of the untreated sample
(Fig. 4B) accompanied by a small increase in absorbance at
the cytochrome c peak area. Sample turbidity is observed at
this HKP1 concentration and higher, probably due to vesicle
aggregation. Increasing the HKP-1 concentration of the vesi-
cles to 23 lM and 46 lM results in a decrease in the vesicle elu-
tion proﬁle and further increase in the peak area of released
cytochrome c (Fig. 4C and D). Precipitation of cytochrome c
can be excluded as the source of turbidity because the similar
results were obtained with vesicles with entrapped buﬀer lack-
ing cytochrome c and treatment of free cytochrome c with pep-
tide did not result in precipitation. At 46 lM HKP1
Fig. 4. Leakage of cytochrome c from vesicles was evaluated by gel
ﬁltration. The proﬁles are identiﬁed as (A), untreated vesicles (B),
11.5 lM HKP-1 (C), 23 lM HKP1 and (D), 46 lM HKP1. Vesicles
elute at 11 ml and released cytochrome c elutes at 33 ml. (E) Relative
peak area of the vesicle (open circles) and cytochrome c (solid squares)
peaks were plotted as a function of HKP1 concentration. The increase
in turbidity (solid circles) was monitored by light scattering at 280 nm
of the resuspended pellet.
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that a signiﬁcant portion is retained in the fused vesicles.
Immunoblotting of the resuspended pellet veriﬁed the presence
of cytochrome c. An alternate explanation for the turbidity is
that under the conditions required for these experiments, the
vesicles are lysed but the retention of the approximately 40%
cytochrome c in the fused vesicles suggests that this is not
the case.4. Discussion
HKPs are synthetic peptides designed to target speciﬁc tissue
for programmed cell death for therapeutic purposes. A com-
mon pro-apoptotic peptide sequence is used and homing se-
quences are swapped to mediate speciﬁc cell surface receptor
interactions. In these experiments, we have shown that HKPs
are suﬃcient to cause the release of cytochrome c from
phospholipid vesicles. Two peptides with diﬀerent homing se-
quences form similar size pores, suggesting a common mecha-
nism and adaptability of these peptides to a variety of tissues.
The vesicles retain interior contents after treatment with pep-
tide, and are therefore not lysed. Fusion or aggregation of ves-
icles may occur. Future experiments will examine the ability of
these peptides to fuse vesicles.Acknowledgement: The work was supported by NIH R15 Grant
GM068431-02A1.
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